Damora Therapeutics, Inc.

CEO, President & Director of Damora Therapeutics Picks Up 2.5% More Stock
Simply Wall Street · 30 Sep 2026
Damora Therapeutics CEO Jennifer Jarrett buys $252,875 in shares
Investing.com · 28 Sep 2026
Using personal funds, CEO Jennifer Jarrett buys Damora Therapeutics (DMRA) shares at $20.23 each.
Stock Titan · 28 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.